학술논문
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers
Document Type
Article
Author
Source
In European Journal of Pharmaceutical Sciences 15 November 2017 109:78-85
Subject
Language
ISSN
0928-0987